Logo image of EPSN

EPSILON ENERGY LTD (EPSN) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:EPSN - CA2943752097 - Common Stock

4.245 USD
-0.1 (-2.41%)
Last: 1/7/2026, 1:56:00 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to EPSN. EPSN was compared to 208 industry peers in the Oil, Gas & Consumable Fuels industry. EPSN is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. EPSN is cheap, but on the other hand it scores bad on growth. This makes EPSN very considerable for value investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

EPSN had positive earnings in the past year.
EPSN had a positive operating cash flow in the past year.
Each year in the past 5 years EPSN has been profitable.
EPSN had a positive operating cash flow in each of the past 5 years.
EPSN Yearly Net Income VS EBIT VS OCF VS FCFEPSN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

1.2 Ratios

EPSN's Return On Assets of 4.66% is fine compared to the rest of the industry. EPSN outperforms 64.42% of its industry peers.
EPSN has a Return On Equity (5.87%) which is in line with its industry peers.
EPSN has a better Return On Invested Capital (7.03%) than 63.46% of its industry peers.
EPSN had an Average Return On Invested Capital over the past 3 years of 10.21%. This is significantly below the industry average of 21.28%.
Industry RankSector Rank
ROA 4.66%
ROE 5.87%
ROIC 7.03%
ROA(3y)11.91%
ROA(5y)9.69%
ROE(3y)14.27%
ROE(5y)11.75%
ROIC(3y)10.21%
ROIC(5y)8.94%
EPSN Yearly ROA, ROE, ROICEPSN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

1.3 Margins

EPSN's Profit Margin of 12.86% is fine compared to the rest of the industry. EPSN outperforms 63.94% of its industry peers.
EPSN's Profit Margin has declined in the last couple of years.
EPSN has a better Operating Margin (29.19%) than 71.15% of its industry peers.
EPSN's Operating Margin has declined in the last couple of years.
With an excellent Gross Margin value of 74.48%, EPSN belongs to the best of the industry, outperforming 86.06% of the companies in the same industry.
EPSN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 29.19%
PM (TTM) 12.86%
GM 74.48%
OM growth 3Y-31.37%
OM growth 5Y-9.53%
PM growth 3Y-39.36%
PM growth 5Y-28.44%
GM growth 3Y-4.33%
GM growth 5Y-0.17%
EPSN Yearly Profit, Operating, Gross MarginsEPSN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so EPSN is still creating some value.
The number of shares outstanding for EPSN has been reduced compared to 1 year ago.
Compared to 5 years ago, EPSN has less shares outstanding
There is no outstanding debt for EPSN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
EPSN Yearly Shares OutstandingEPSN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
EPSN Yearly Total Debt VS Total AssetsEPSN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 2.80 indicates that EPSN is not a great score, but indicates only limited risk for bankruptcy at the moment.
With an excellent Altman-Z score value of 2.80, EPSN belongs to the best of the industry, outperforming 80.77% of the companies in the same industry.
EPSN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.8
ROIC/WACC0.8
WACC8.81%
EPSN Yearly LT Debt VS Equity VS FCFEPSN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

EPSN has a Current Ratio of 1.93. This is a normal value and indicates that EPSN is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.93, EPSN is in the better half of the industry, outperforming 75.96% of the companies in the same industry.
A Quick Ratio of 1.93 indicates that EPSN should not have too much problems paying its short term obligations.
EPSN has a Quick ratio of 1.93. This is in the better half of the industry: EPSN outperforms 78.37% of its industry peers.
Industry RankSector Rank
Current Ratio 1.93
Quick Ratio 1.93
EPSN Yearly Current Assets VS Current LiabilitesEPSN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

3

3. Growth

3.1 Past

EPSN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 96.00%, which is quite impressive.
Measured over the past years, EPSN shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -22.77% on average per year.
Looking at the last year, EPSN shows a very strong growth in Revenue. The Revenue has grown by 46.76%.
Measured over the past years, EPSN shows a small growth in Revenue. The Revenue has been growing by 3.38% on average per year.
EPS 1Y (TTM)96%
EPS 3Y-43.6%
EPS 5Y-22.77%
EPS Q2Q%350%
Revenue 1Y (TTM)46.76%
Revenue growth 3Y-9.41%
Revenue growth 5Y3.38%
Sales Q2Q%23.22%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y206%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year38.2%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPSN Yearly Revenue VS EstimatesEPSN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
EPSN Yearly EPS VS EstimatesEPSN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2020 2023 2024 2025 0 0.1 0.2 0.3 0.4

8

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 8.66, which indicates a very decent valuation of EPSN.
84.13% of the companies in the same industry are more expensive than EPSN, based on the Price/Earnings ratio.
EPSN is valuated cheaply when we compare the Price/Earnings ratio to 27.17, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 8.67, which indicates a very decent valuation of EPSN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of EPSN indicates a somewhat cheap valuation: EPSN is cheaper than 79.33% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of EPSN to the average of the S&P500 Index (23.79), we can say EPSN is valued rather cheaply.
Industry RankSector Rank
PE 8.66
Fwd PE 8.67
EPSN Price Earnings VS Forward Price EarningsEPSN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

EPSN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. EPSN is cheaper than 85.58% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, EPSN is valued a bit cheaper than the industry average as 75.48% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 10.38
EV/EBITDA 3.62
EPSN Per share dataEPSN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

EPSN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
EPSN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0.04
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.39%, EPSN is a good candidate for dividend investing.
EPSN's Dividend Yield is a higher than the industry average which is at 3.96.
Compared to an average S&P500 Dividend Yield of 1.94, EPSN pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.39%

5.2 History

EPSN has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years2
EPSN Yearly Dividends per shareEPSN Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.05 0.1 0.15 0.2

5.3 Sustainability

EPSN pays out 93.55% of its income as dividend. This is not a sustainable payout ratio.
DP93.55%
EPS Next 2YN/A
EPS Next 3YN/A
EPSN Yearly Income VS Free CF VS DividendEPSN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M
EPSN Dividend Payout.EPSN Dividend Payout, showing the Payout Ratio.EPSN Dividend Payout.PayoutRetained Earnings

EPSILON ENERGY LTD

NASDAQ:EPSN (1/7/2026, 1:56:00 PM)

4.245

-0.1 (-2.41%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-05 2025-11-05/amc
Earnings (Next)03-17 2026-03-17
Inst Owners61.36%
Inst Owner Change0%
Ins Owners6.94%
Ins Owner Change0.43%
Market Cap103.15M
Revenue(TTM)45.71M
Net Income(TTM)5.88M
Analysts82.86
Price Target8.57 (101.88%)
Short Float %3.42%
Short Ratio4.55
Dividend
Industry RankSector Rank
Dividend Yield 5.39%
Yearly Dividend0.25
Dividend Growth(5Y)N/A
DP93.55%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)163.48%
Min EPS beat(2)132.84%
Max EPS beat(2)194.12%
EPS beat(4)3
Avg EPS beat(4)77.96%
Min EPS beat(4)-41.18%
Max EPS beat(4)194.12%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-13.62%
Min Revenue beat(2)-23.45%
Max Revenue beat(2)-3.78%
Revenue beat(4)1
Avg Revenue beat(4)1.29%
Min Revenue beat(4)-23.45%
Max Revenue beat(4)35.29%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 8.66
Fwd PE 8.67
P/S 2.26
P/FCF 10.38
P/OCF 3.98
P/B 1.03
P/tB 1.03
EV/EBITDA 3.62
EPS(TTM)0.49
EY11.54%
EPS(NY)0.49
Fwd EY11.53%
FCF(TTM)0.41
FCFY9.63%
OCF(TTM)1.07
OCFY25.11%
SpS1.88
BVpS4.12
TBVpS4.12
PEG (NY)0.04
PEG (5Y)N/A
Graham Number6.74
Profitability
Industry RankSector Rank
ROA 4.66%
ROE 5.87%
ROCE 11.46%
ROIC 7.03%
ROICexc 7.9%
ROICexgc 7.9%
OM 29.19%
PM (TTM) 12.86%
GM 74.48%
FCFM 21.73%
ROA(3y)11.91%
ROA(5y)9.69%
ROE(3y)14.27%
ROE(5y)11.75%
ROIC(3y)10.21%
ROIC(5y)8.94%
ROICexc(3y)15.79%
ROICexc(5y)13.41%
ROICexgc(3y)15.79%
ROICexgc(5y)13.41%
ROCE(3y)16.64%
ROCE(5y)14.58%
ROICexgc growth 3Y-47.2%
ROICexgc growth 5Y-12.62%
ROICexc growth 3Y-47.2%
ROICexc growth 5Y-12.62%
OM growth 3Y-31.37%
OM growth 5Y-9.53%
PM growth 3Y-39.36%
PM growth 5Y-28.44%
GM growth 3Y-4.33%
GM growth 5Y-0.17%
F-Score7
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 129.79%
Cap/Sales 34.94%
Interest Coverage 1347.55
Cash Conversion 101.01%
Profit Quality 168.97%
Current Ratio 1.93
Quick Ratio 1.93
Altman-Z 2.8
F-Score7
WACC8.81%
ROIC/WACC0.8
Cap/Depr(3y)242.3%
Cap/Depr(5y)173.79%
Cap/Sales(3y)62.73%
Cap/Sales(5y)45.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)96%
EPS 3Y-43.6%
EPS 5Y-22.77%
EPS Q2Q%350%
EPS Next Y206%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)46.76%
Revenue growth 3Y-9.41%
Revenue growth 5Y3.38%
Sales Q2Q%23.22%
Revenue Next Year38.2%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y195.55%
EBIT growth 3Y-37.82%
EBIT growth 5Y-6.47%
EBIT Next Year539.19%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y106.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y12.88%
OCF growth 3Y-5.61%
OCF growth 5Y5.32%

EPSILON ENERGY LTD / EPSN FAQ

What is the ChartMill fundamental rating of EPSILON ENERGY LTD (EPSN) stock?

ChartMill assigns a fundamental rating of 6 / 10 to EPSN.


What is the valuation status for EPSN stock?

ChartMill assigns a valuation rating of 8 / 10 to EPSILON ENERGY LTD (EPSN). This can be considered as Undervalued.


How profitable is EPSILON ENERGY LTD (EPSN) stock?

EPSILON ENERGY LTD (EPSN) has a profitability rating of 6 / 10.


How financially healthy is EPSILON ENERGY LTD?

The financial health rating of EPSILON ENERGY LTD (EPSN) is 8 / 10.


What is the earnings growth outlook for EPSILON ENERGY LTD?

The Earnings per Share (EPS) of EPSILON ENERGY LTD (EPSN) is expected to grow by 206% in the next year.